end,filed,form,Name,Ticker,CIK,Currency,AccountsAndOtherReceivablesNetCurrent,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsPayableTradeCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AllocatedShareBasedCompensationExpense,AllowanceForDoubtfulAccountsReceivable,AmortizationOfIntangibleAssets,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,AvailableForSaleSecuritiesDebtSecurities,CapitalLeaseObligationsIncurred,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockParOrStatedValuePerShare,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValueOutstanding,ComprehensiveIncomeNetOfTax,CostOfRevenue,CostsAndExpenses,CurrentFederalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,DebtSecuritiesAvailableForSaleUnrealizedGainLoss,DebtSecuritiesCurrent,DebtSecuritiesNoncurrent,DeferredFederalIncomeTaxExpenseBenefit,DeferredForeignIncomeTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredIncomeTaxLiabilities,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesLeasingArrangements,DeferredTaxLiabilitiesPropertyPlantAndEquipment,Depreciation,DueToRelatedPartiesCurrent,DueToRelatedPartiesNoncurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationTaxCreditsForeign,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FinanceLeaseLiabilityPaymentsDue,FinanceLeasePrincipalPayments,FiniteLivedIntangibleAssetsAccumulatedAmortization,FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths,FiniteLivedIntangibleAssetsAmortizationExpenseYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseYearFour,FiniteLivedIntangibleAssetsAmortizationExpenseYearThree,FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo,FiniteLivedIntangibleAssetsGross,FiniteLivedIntangibleAssetsNet,GeneralAndAdministrativeExpense,HeldToMaturitySecurities,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxExpenseBenefit,IncomeTaxesPaid,IncomeTaxesPaidNet,IncomeTaxesReceivable,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInInventories,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPrepaidExpense,IncreaseDecreaseInReceivables,InterestIncomeExpenseNonoperatingNet,InterestIncomeOther,InterestReceivable,InterestReceivableCurrent,InventoryFinishedGoods,InventoryFinishedGoodsNetOfReserves,InventoryNet,InventoryRawMaterialsNetOfReserves,InventoryWorkInProcess,InventoryWorkInProcessNetOfReserves,InvestmentsFairValueDisclosure,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermPurchaseCommitmentAmount,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NoncurrentAssets,NumberOfOperatingSegments,NumberOfReportingUnits,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseWeightedAverageDiscountRatePercent,OperatingLossCarryforwards,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax,OtherComprehensiveIncomeLossNetOfTax,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherNoncashIncomeExpense,OtherOperatingIncomeExpenseNet,OtherReceivablesNetCurrent,PaymentsForSoftware,PaymentsToAcquireIntangibleAssets,PaymentsToAcquireLeaseReceivables,PaymentsToAcquireMarketableSecurities,PaymentsToAcquireOtherInvestments,PaymentsToAcquireOtherProductiveAssets,PrepaidAdvertising,PrepaidExpenseAndOtherAssetsCurrent,PrepaidExpenseCurrent,PrepaidInsurance,ProceedsFromInterestReceived,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOrSaleOfEquity,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromStockOptionsExercised,ProceedsFromWarrantExercises,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,PurchaseObligation,PurchaseObligationDueInNextTwelveMonths,PurchaseObligationDueInSecondYear,PurchaseObligationDueInThirdYear,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SaleOfStockConsiderationReceivedOnTransaction,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,ShortTermLeaseCost,ShortTermLeasePayments,StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TangibleAssetImpairmentCharges,ValuationAllowanceDeferredTaxAssetChangeInAmount,VariableLeaseCost,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,PaymentsForCapitalImprovements,RestrictedCash,RestrictedCashAndCashEquivalents,SellingGeneralAndAdministrativeExpense,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2020-12-31,2021-02-24,10-K,Aurinia Pharmaceuticals Inc.,AUPH,CIK0001600620,USD,0.0,24797000.0,2635000.0,179000.0,-805000.0,39383000.0,17454000.0,,17454000.0,0.0,1289000.0,15737000.0,463661000.0,419427000.0,422709000.0,0.0,,272350000.0,272350000.0,-33669000.0,0.0,126725000.0,126725000.0,944328000.0,-102680000.0,0.0,154408000.0,0.0,-94000.0,-94000.0,0.0,125979000.0,24380000.0,0.0,0.0,0.0,1365000.0,2718000.0,103157000.0,0.0,1365000.0,80087000.0,5243000.0,4808000.0,6295000.0,101792000.0,1173000.0,192000.0,82000.0,6000000.0,,-0.9299999999999999,-0.92,-0.9299999999999999,0.001,0.268,-0.26,0.061,0.045,0.001,-0.024,11361000.0,51500000.0,,,9120000.0,7000000.0,7000000.0,7000000.0,7000000.0,7000000.0,18452000.0,9332000.0,95983000.0,150400000.0,-61024000.0,-102774000.0,-41750000.0,-94000.0,261000.0,,481000.0,13620000.0,13927000.0,8407000.0,0.0,-2559000.0,650000.0,,1516000.0,500000.0,486000.0,0.0,0.0,13927000.0,0.0,13927000.0,13927000.0,150359000.0,944000.0,11283000.0,6773000.0,287000.0,1109000.0,1085000.0,1061000.0,968000.0,,2876000.0,55911000.0,463661000.0,31997000.0,,194375000.0,-158186000.0,-69858000.0,-110754000.0,4786000.0,1.0,,212490000.0,-112342000.0,653000.0,8407000.0,788000.0,7619000.0,267000.0,5489000.0,0.052,307800000.0,6616000.0,1018000.0,247000.0,0.0,,,6412000.0,16295000.0,-9477000.0,-6809000.0,51000.0,1675000.0,84000.0,0.0,202951000.0,0.0,5584000.0,3701000.0,7171000.0,7171000.0,2054000.0,1884000.0,187732000.0,573143000.0,52108000.0,6642000.0,1000.0,4965000.0,4786000.0,2298000.0,2233000.0,65000.0,0.0,50327000.0,-575156000.0,100148000.0,,,17454000.0,0.0055,0.0,0.52,15800000.0,5063000.0,6.94,236000.0,11.82,7129000.0,5.58,35891000.0,14047000.0,11.35,3246000.0,8.03,4.39,15.61,14900000.0,288000.0,5804000.0,1000.0,407750000.0,1593000.0,187732000.0,6643000.0,0.0,30300000.0,3000.0,,118473000.0,,,,0.0,0.0,96000000.0,13100000.0,
2021-03-31,2021-05-06,10-Q,Aurinia Pharmaceuticals Inc.,AUPH,CIK0001600620,USD,1187000.0,17694000.0,2182000.0,346000.0,-799000.0,43889000.0,7821000.0,,7821000.0,0.0,523000.0,15785000.0,417078000.0,372246000.0,360862000.0,115200000.0,,156591000.0,156591000.0,-115759000.0,,128121000.0,128121000.0,952673000.0,-50373000.0,48000.0,51457000.0,,,,6000.0,191668000.0,12603000.0,,,,,,,,,,,,,,,,165000.0,2000000.0,,-0.4,-0.4,-0.4,,,,,,,,5785000.0,36600000.0,91000000.0,,9642000.0,,,,,,19496000.0,9854000.0,39282000.0,89100000.0,,-50371000.0,,8000.0,,,,-7103000.0,2009000.0,,-229000.0,-308000.0,1187000.0,,172000.0,400000.0,,1569000.0,,15936000.0,,14367000.0,,204271000.0,309000.0,11657000.0,,1144000.0,,1110000.0,1085000.0,1061000.0,484000.0,2776000.0,46850000.0,417078000.0,21151000.0,25400000.0,5029000.0,-67247000.0,-53541000.0,-50379000.0,,1.0,1.0,51457000.0,-50543000.0,261000.0,8881000.0,1075000.0,7806000.0,,5761000.0,0.0518,,9727000.0,1180000.0,11856000.0,6000.0,0.0,6000.0,2382000.0,17893000.0,2111000.0,-1771000.0,,1039000.0,6000.0,11838000.0,115168000.0,,136000.0,4139000.0,6864000.0,6864000.0,939000.0,425000.0,0.0,,60940000.0,4999000.0,30000.0,5104000.0,4758000.0,,,,,9833000.0,-625535000.0,914000.0,,,7821000.0,0.0028,0.0,0.66,16000000.0,,,,,,6.72,,,,,,,,,7000.0,,31000.0,370228000.0,,,4999000.0,,,41000.0,,127401000.0,,,,,,,,
2021-06-30,2021-08-05,10-Q,Aurinia Pharmaceuticals Inc.,AUPH,CIK0001600620,USD,4418000.0,25831000.0,2535000.0,506000.0,-792000.0,51022000.0,7753000.0,,7753000.0,0.0,536000.0,,386268000.0,349689000.0,323741000.0,153600000.0,,121561000.0,121561000.0,,,128396000.0,128396000.0,954572000.0,-47003000.0,308000.0,53754000.0,,,,7000.0,197176000.0,5004000.0,,,,,,,,,,,,,,,,200000.0,2000000.0,,-0.37,,-0.37,,,,,,,,10817000.0,38200000.0,96000000.0,,10048000.0,,,,,,19339000.0,9291000.0,43786000.0,48500000.0,,-46992000.0,,18000.0,,,,,,,,,,,142000.0,300000.0,,3585000.0,,17376000.0,,13791000.0,,166579000.0,307000.0,11598000.0,,1147000.0,,1109000.0,1085000.0,1061000.0,423000.0,2662000.0,54011000.0,386268000.0,29315000.0,,,,,-47010000.0,,,,53754000.0,-47134000.0,261000.0,8936000.0,1112000.0,7824000.0,,5615000.0,0.0519,,7996000.0,886000.0,11856000.0,7000.0,0.0,7000.0,2372000.0,16872000.0,,967000.0,,,,,,,,4092000.0,9158000.0,9158000.0,87000.0,,,,,,,5319000.0,4813000.0,,,,,10091000.0,-672545000.0,6620000.0,,,,,,,,,,,,,,,,,,,,,,7000.0,,0.0,332257000.0,,,1279000.0,,,39000.0,128222000.0,,128222000.0,,,,,,,
2021-09-30,2021-11-03,10-Q,Aurinia Pharmaceuticals Inc.,AUPH,CIK0001600620,USD,9814000.0,29970000.0,3263000.0,673000.0,-794000.0,54607000.0,7092000.0,,7092000.0,0.0,517000.0,,360066000.0,329219000.0,286400000.0,207300000.0,,57587000.0,57587000.0,,,129570000.0,129570000.0,967159000.0,-50257000.0,254000.0,65020000.0,,,,-2000.0,228813000.0,0.0,,,,,,,,,,,,,,,,200000.0,2000000.0,,-0.39,,-0.39,,,,,,,,14520000.0,16900000.0,84000000.0,,10543000.0,,,,,,19469000.0,8926000.0,44128000.0,21500000.0,,-50247000.0,,8000.0,,,,,,,,,,106000.0,,100000.0,,,5002000.0,19293000.0,2217000.0,,12074000.0,228813000.0,312000.0,11452000.0,,1143000.0,,1109000.0,1085000.0,1061000.0,281000.0,2546000.0,61894000.0,360066000.0,37537000.0,,,,,-50255000.0,,,,65020000.0,-50353000.0,261000.0,8906000.0,1111000.0,7795000.0,,5532000.0,0.052,,8322000.0,728000.0,11838000.0,-2000.0,0.0,-2000.0,6456000.0,16562000.0,,-55000.0,,,,,,,,5871000.0,13712000.0,13712000.0,2524000.0,,,,,,,5224000.0,4551000.0,,,,,20066000.0,-722800000.0,14667000.0,,,,,,,,,,,,,,,,,,,,,,7000.0,,6000.0,298172000.0,,,9074000.0,,,44000.0,128443000.0,,128443000.0,,,,,,,
2021-12-31,2022-02-28,10-K,Aurinia Pharmaceuticals Inc.,AUPH,CIK0001600620,USD,15414000.0,34947000.0,3879000.0,836000.0,-852000.0,59014000.0,31243000.0,,31243000.0,,2098000.0,12329000.0,543367000.0,513324000.0,466078000.0,214900000.0,,231643000.0,231900000.0,-40450000.0,0.0,141600000.0,141600000.0,1177051000.0,-181013000.0,1091000.0,226340000.0,0.0,760000.0,760000.0,-47000.0,234178000.0,0.0,0.0,0.0,0.0,2193000.0,1086000.0,143541000.0,0.0,2193000.0,120274000.0,6126000.0,6059000.0,,141348000.0,1356000.0,837000.0,663000.0,,,-1.65,,-1.65,-0.004,0.268,-0.218,-0.001,0.045,-0.008,0.0,18242000.0,,79000000.0,,11066000.0,6700000.0,6700000.0,6700000.0,6700000.0,6700000.0,19470000.0,8404000.0,171438000.0,19200000.0,-180374000.0,-180206000.0,168000.0,760000.0,257000.0,,,4076000.0,5644000.0,332000.0,-247000.0,5335000.0,15415000.0,,529000.0,100000.0,,,4543000.0,19326000.0,2217000.0,,12566000.0,234178000.0,1239000.0,11171000.0,5638000.0,1143000.0,1135000.0,1109000.0,1085000.0,1061000.0,,2432000.0,64276000.0,543367000.0,40646000.0,,221112000.0,-103870000.0,-157692000.0,-214288000.0,4418000.0,1.0,,56109000.0,-213440000.0,1045000.0,8739000.0,1059000.0,7680000.0,646000.0,5383000.0,0.052,429800000.0,8443000.0,796000.0,11838000.0,-47000.0,,-47000.0,4640000.0,15950000.0,-903000.0,-574000.0,,1198000.0,6000.0,11838000.0,438958000.0,6000000.0,297000.0,5316000.0,12506000.0,12506000.0,1632000.0,749000.0,196740000.0,,354427000.0,24007000.0,365000.0,5254000.0,4418000.0,,,,,51139000.0,-756122000.0,69009000.0,,,31243000.0,0.0046,0.0,0.66,,5849000.0,11.87,1012000.0,13840.0,2277000.0,7.34,121141000.0,12074000.0,12.84,,,7210.0,14440.0,24900000.0,27000.0,419000.0,365000.0,479091000.0,3238000.0,196740000.0,23421000.0,0.0,39600000.0,167000.0,,129369000.0,,19056000.0,,300000.0,257000.0,171400000.0,50300000.0,585000.0
